Oncoinvent reports positive data from phase 1/2a trial of Radspherin in patients with colorectal peritoneal metastases: Oslo, Norway Thursday, June 19, 2025, 11:00 Hrs [IST] Oncoi ...

Bengaluru: What began as a celebration turned into tragedy — and for months, a slice of cake was wrongly blamed. A final investigation has now confirm.

ASCO 2025 overall survival data bolster IMNN-001's potential in advanced ovarian cancer, supported by robust translational results at ESMO Results from OVATION 2 Study reinforce IMNN-001 mechanism of ...

Data demonstrate sustained peritoneal disease control and reinforce the potential of Oncoinvent's novel radiopharmaceutical therapy to target peritoneal disease in colorectal cancer OSLO ...